SINGAPORE, April 2, 2025 — Serv Medical announced that its Surgery Clinical Decision Support System (CDSS) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This authorization allows the company to introduce its AI-powered surgical decision support technology into the U.S. market.
The clearance marks an important milestone for Serv Medical as it expands globally, bringing data-driven tools to support surgical teams with standardized, efficient, and safer clinical decision-making.
About Serv Medical
Serv Medical is a Singapore-based award winning, internationally recognized, healthcare big data and AI company at the forefront of digital healthcare solutions. By leveraging advanced technologies, Serv Medical enhances medical workflow efficiency and quality of care, enabling professionals across the healthcare spectrum to extract valuable insights from data pools. Through their innovative offerings, Serv Medical seeks to play a pivotal role in shaping the future of healthcare delivery. To learn more, visit www.servmedical.co.
————————
Media contacts:
Charles Poon,
Media Relations, Serv Medical